Le Lézard
Classified in: Health, Science and technology, Business
Subject: TAKEOVERS/ LETTER of INTENT

SEB Acquires Aon Hewitt's Mid-Market Health and Welfare Benefits Administration Business in Canada


MISSISSAUGA, ONTARIO--(Marketwired - April 3, 2017) - Smart Employee Benefits Inc. ("SEB" or the "Company") (TSX VENTURE:SEB) is a leading provider of software, solutions and services which manage mission critical systems and infrastructure for corporate and government clients. SEB is pleased to announce it has entered into an agreement with Aon Hewitt Inc. ("Aon Hewitt") on March 31, 2017, to acquire Aon Hewitt's mid-market health and welfare administration business in Canada (the "Admin Business"). The transaction also includes a strategic alliance partnership agreement with Aon. This Admin Business represents 48 clients, many with globally recognized brands, representing over 250,000 plan members across Canada. As part of this transaction, SEB is acquiring several complementary technology platforms and will add approximately 150 employees from across Canada and India. 

"This is a benchmark transaction in developing SEB's Benefits processing business," states John McKimm, President/CEO of SEB. The transaction also creates a strategic relationship with one of the largest benefits consulting companies in the world. "We believe SEB's technology expertise will add significant value to the clients of the Admin Business in Canada. We are looking forward to a strategic business relationship with Aon Hewitt on future business initiatives".

States Mohamad El Chayah, President of SEB Administrative Services Inc., "This transaction is consistent with our goal of driving meaningful growth across SEB Administrative Services Inc. with innovative products, technologies and services that automate clients' business processes and enhance clients' business outcomes. SEB has made a substantial investment over the past five years in business process automation solutions focused on health benefits processing. SEB's Benefits Exchange Platform includes fully integrated administration, adjudication, claims payment, billing, real time reporting, real time fraud identification and real time analytics for all benefit types in one environment. SEB's Benefits processing solutions also include a fully automated, content-rich health and wellness platform, document management solutions, standalone fraud and analytics solutions and administration and underwriting solutions, which automate the application, underwriting and administration of new insurance product sales. This transaction with Aon Hewitt is one of multiple transactions SEB will be executing in 2017 in the health benefits processing space."

The transaction was effective on Friday, March 31, 2017. Financial terms were not disclosed.

About SEB

SEB's global infrastructure is comprised of two operating divisions: Technology and Benefits. The Technology Division currently serves corporate and government clients across Canada and internationally. The Benefits Division offers SAAS and BPO solutions in the Health Benefits Sector to corporate and government clientele. The Benefits Division operates as a client of the Technology Division. The Technology Division is a critical competitive advantage in supporting the implementation of SEB's benefits processing solutions into client environments. Benefits processing is a high-growth specialty practice area for SEB.

The core expertise of both divisions is automating and managing business processes utilizing SEB proprietary software solutions combined with solutions of third parties through joint ventures and partnerships.

Acquisitions, joint ventures, and RFP wins will continue to be dominant influences in driving growth in both the Technology and Benefits Divisions.

Forward-Looking Statements

This news release is intended for information purposes only. Statements made in this news release may contain "forward looking" information about the company's future business prospects. These statements while expressed in good faith and believed to have a reasonable basis are subject to risk and uncertainties that could cause actual results to differ materially from those set forth or implied by such forward looking statements. Investors should consult a professional advisor before making any investment decision. 

For further information about SEB, please visit www.seb-inc.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: